TABLE 1.
INHIBITION OF miR-25 REGULATES EXPRESSION OF INFLAMMATORY MEDIATORS IN CYTOKINE-STIMULATED AIRWAY SMOOTH MUSCLE CELLS
| Gene Name | Fold Regulation by Anti–miR-25 |
|---|---|
| Chemokine (C-C motif) ligand 5; CCL5 | −44.76 |
| Interleukin 18; IL18 | −2.53 |
| Chemokine (C-C motif) ligand 11; CCL11 | −2.05 |
| Interleukin 23, alpha subunit p19; IL23A | −1.98 |
| Chemokine (C-C motif) receptor 2; CCR2 | −1.83 |
| CD86 molecule; CD86 | −1.77 |
| Interleukin 18 receptor 1; IL18R1 | −1.69 |
| Fas ligand; FASLG | −1.60 |
| CD40 ligand; CD40LG | −1.56 |
| Inhibin, alpha; INHA | −1.55 |
| Suppressor of cytokine signaling 2; SOCS2 | 1.64 |
| NFAT, cytoplasmic, calcineurin-dependent 2; NFATC2 | 1.74 |
| Growth factor independent 1 transcription repressor; GFI1 | 1.88 |
| CD27 molecule; CD27 | 1.95 |
| Interleukin 6 receptor; IL6R | 2.21 |
| Hepatitis A virus cellular receptor 2; HAVCR2 | 2.23 |
| Interleukin 12 receptor, beta 2; IL12RB2 | 2.30 |
| Chemokine (C-C motif) receptor 5; CCR5 | 2.32 |
| Tumor necrosis factor; TNF | 2.57 |
| Linker for activation of T cells; LAT | 2.72 |